Literature DB >> 3263981

SPECT with [99mTc]-d,l-hexamethyl-propylene amine oxime (HM-PAO) compared with regional cerebral blood flow measured by PET: effects of linearization.

Y Yonekura1, S Nishizawa, T Mukai, T Fujita, H Fukuyama, M Ishikawa, H Kikuchi, J Konishi, A R Andersen, N A Lassen.   

Abstract

In order to validate the use of technetium-99m-d,l-hexamethylpropyleneamine oxime (HM-PAO) as a flow tracer, a total of 21 cases were studied with single photon emission computerized tomography (SPECT), and compared to regional cerebral blood flow (rCBF) measured by position emission tomography (PET) using the oxygen-15 CO2 inhalation technique. Although HM-PAO SPECT and rCBF PET images showed a similar distribution pattern the HM-PAO SPECT image showed less contrast between high and low activity flow regions than the rCBF image and a nonlinear relationship between HM-PAO activity and rCBF was shown. Based on the assumption of flow-dependent backdiffusion of HM-PAO from the brain, we applied a "linearization algorithm" to correct the HM-PAO SPECT images. The corrected HM-PAO SPECT images revealed a good linear correlation with rCBF (r = 0.901, p less than 0.001). The results indicated HM-PAO can be used as a flow tracer with SPECT after proper correction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263981     DOI: 10.1038/jcbfm.1988.36

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  19 in total

1.  Motor stimulation response by technetium-99m hexamethylpropylene amine oxime split-dose method and single photon emission tomography.

Authors:  P Pantano; V Di Piero; M Ricci; C Fieschi; L Bozzao; G L Lenzi
Journal:  Eur J Nucl Med       Date:  1992

2.  High resolution SPECT, small deep infarcts and diaschisis.

Authors:  J V Bowler; D C Costa; B E Jones; T J Steiner; J P Wade
Journal:  J R Soc Med       Date:  1992-03       Impact factor: 5.344

3.  Technetium-99m hexamethylpropylene amine oxime single-photon emission tomography of regional cerebral blood flow in insulin-dependent diabetes.

Authors:  B Keymeulen; K de Metz; R Cluydts; A Bossuyt; G Somers
Journal:  Eur J Nucl Med       Date:  1996-02

4.  In vivo photoacoustic microscopy of human cuticle microvasculature with single-cell resolution.

Authors:  Hsun-Chia Hsu; Lidai Wang; Lihong V Wang
Journal:  J Biomed Opt       Date:  2016-05-01       Impact factor: 3.170

5.  Effects of non-linear flow and spatial orientation on technetium-99m hexamethylpropylene amine oxime single-photon emission tomography.

Authors:  S J Stapleton; C B Caldwell; L E Ehrlich; C L Leonhardt; S E Black; M J Yaffe
Journal:  Eur J Nucl Med       Date:  1995-09

6.  Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia.

Authors:  K M MacLeod; D A Hepburn; I J Deary; G M Goodwin; N Dougall; K P Ebmeier; B M Frier
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

7.  Single photon emission computed tomography in patients with acute hydrocephalus or with cerebral ischaemia after subarachnoid haemorrhage.

Authors:  D Hasan; J van Peski; I Loeve; E P Krenning; M Vermeulen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

8.  Evaluation of technetium-99m exametazime stabilised with cobalt chloride as a blood flow tracer in focal cerebral ischaemia.

Authors:  G Gartshore; P Bannan; J Patterson; B Higley; J McCulloch
Journal:  Eur J Nucl Med       Date:  1994-09

9.  Changes in regional brain perfusion during functional brain activation: comparison of [(64)Cu]-PTSM with [(14)C]-Iodoantipyrine.

Authors:  D P Holschneider; J Yang; T R Sadler; N B Galifianakis; M H Bozorgzadeh; J R Bading; P S Conti; J-M I Maarek
Journal:  Brain Res       Date:  2008-07-19       Impact factor: 3.252

Review 10.  Mapping brain function in freely moving subjects.

Authors:  Daniel P Holschneider; Jean-Michel I Maarek
Journal:  Neurosci Biobehav Rev       Date:  2004-09       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.